Ronald van Vollenhoven
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies 308
- Systemic Lupus Erythematosus Research 247
- Hematology top 0.05%
- Autoimmune and Inflammatory Disorders Research 116
- Immunology top 0.05%
- Biosimilars and Bioanalytical Methods 46
- T-cell and B-cell Immunology 35
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research 125
-
- Monoclonal and Polyclonal Antibodies Research 122
-
- Lymphoma Diagnosis and Treatment 94
- Co-authors
- Paul EmeryRoy FleischmannKarel PavelkáLars KlareskogEdward KeystoneDésirée van der HeijdeStanley CohenGerd R Burmester
- Cited by
- RheumatologyHematologyImmunology
- Journals
- New England Journal of Medicine (4 papers)The Lancet (8 papers)SHILAP Revista de lepidopterología (4 papers)
- Partner nations
- SwedenUnited StatesNetherlands
In The Last Decade
Ronald van Vollenhoven
484 papers receiving 26.8k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Rheumatology 20.6k
- Hematology 6.8k
- Immunology 10.0k
- Genetics 4.4k
- Radiology, Nuclear Medicine and Imaging 4.8k
Countries citing papers authored by Ronald van Vollenhoven
This map shows the geographic impact of Ronald van Vollenhoven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald van Vollenhoven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald van Vollenhoven more than expected).
Fields of papers citing papers by Ronald van Vollenhoven
This network shows the impact of papers produced by Ronald van Vollenhoven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald van Vollenhoven. The network helps show where Ronald van Vollenhoven may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ronald van Vollenhoven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 20 | |
| 10 | 2022 | 31 | |
| 11 | 2021 | 2 | |
| 12 | 2019 | 57 | |
| 13 | 2019 | 41 | |
| 14 | Rheumatologists' guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback. | 2018 | 10 |
| 15 | 2017 | 53 | |
| 16 | 2017 | 183 | |
| 17 | 2016 | 72 | |
| 18 | 2015 | 27 | |
| 19 | In rheumatoid arthritis patients with stable low disease activity on methotrexate plus etanercept, continuation of etanercept 50 mg weekly or 25 mg weekly are both clinically superior to discontinuation: Results from a randomized, 3-armed, double-blind clinical trial. | 2012 | 3 |
| 20 | Efficacy of different doses of rituximab for the treatment of rheumatoid arthritis: Data from the CERERRA collaboration. | 2011 | 1 |
About Ronald van Vollenhoven
Ronald van Vollenhoven is a scholar working on Rheumatology, Genetics and Hematology, having authored 512 papers that have together received 27.7k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (308 papers), Systemic Lupus Erythematosus Research (247 papers), Chronic Lymphocytic Leukemia Research (125 papers), Monoclonal and Polyclonal Antibodies Research (122 papers), Autoimmune and Inflammatory Disorders Research (116 papers), Lymphoma Diagnosis and Treatment (94 papers), Biosimilars and Bioanalytical Methods (46 papers) and T-cell and B-cell Immunology (35 papers). The work is most often cited by research in Rheumatology (20.6k citations), Hematology (6.8k citations) and Immunology (10.0k citations). Ronald van Vollenhoven has collaborated with scholars based in Sweden, United States and Netherlands. Frequent co-authors include Paul Emery, Roy Fleischmann, Karel Pavelká, Lars Klareskog, Edward Keystone, Désirée van der Heijde, Stanley Cohen, Gerd R Burmester, Robert Landewé and James L. McGuire. Their work appears in journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.